Questions About the Crestor Study
In a new study, AstraZeneca’s cholesterol drug Crestor lowered the risk of heart attacks among healthy patients, but Dr. Steven Greer, founder and CEO of The Healthcare Channel, takes issu...
The Wall Street Journal
-
Mon, 10 Nov 2008 19:08:47 -0500
Found on Truveo